NRBO Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NRBO shares is 14, representing 12.71% of the company's common stock.

SABBY MANAGEMENT, LLC, in the last quarter, reduced its stake in NRBO by -74.97% restricting it's holding to 93.38 thousand shares of worth nearly $45.00K. CITADEL ADVISORS LLC also lessened -14.01% of the NRBO shares from its portfolio, reducing its holding to 13.5 thousand shares of worth $6.00K. SIMPLEX TRADING, LLC also shunned NRBO shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, SUSQUEHANNA INTERNATIONAL GROUP, LLP increased its stake in NRBO by 100% in the last quarter. The institutional holder raised its holding to 108.54 thousand shares having worth more than $51.00K. TOWER RESEARCH CAPITAL LLC (TRC) also added 852.13% more shares of NRBO to its portfolio, raising its holding to 14.72 thousand shares of worth $7.00K. TRUVESTMENTS CAPITAL LLC also increased its NRBO shares holding by 100% which brought its holding to 29 shares worth -.

The insider with the most stakes in NRBO is DONG-A ST CO., LTD , 10 percent owner at the company. Additionally, NRBO stock is highly held by Chair & Chief Scientific Off. Bisgaier Charles PhD and Interim President & CEO Gullans Steven R. Ph.D. among others.

Company executives, directors, and other insiders own 65.23% percent of NeuroBo Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 1 transaction(s) in which NRBO insiders have sold stock, totaling 407 shares. Insiders that have sold shares include DONG-A ST CO., LTD.

There have been 1 transaction(s) during the past 6-months in which NeuroBo Pharmaceuticals, Inc. insiders have bought stock, totalling 2544530 shares

Around 7.89M NeuroBo Pharmaceuticals, Inc. shares are held by insiders, which represents about 65.23% of NRBO stock.

NRBO 10 percent owner, DONG-A ST CO., LTD holds the largest portfolio of the company's shares. NRBO shares owned by DONG-A total nearly 2.54 million.

SUSQUEHANNA INTERNATIONAL GROUP, LLP is the largest institutional owner in NRBO which holds 108.54 thousand shares worth $51.00K or 0.41% of the total NRBO shares outstanding followed by SABBY MANAGEMENT, LLC with ownership of 93.38 thousand shares representing 0.35% of the NRBO ownership. GEODE CAPITAL MANAGEMENT, LLC is the third largest stakeholder with 65.29 thousand shares or 0.24% of the ownership worth more than $30.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NRBO is concerned, it is a stock which is not optionable.

Number of NRBO shares short is 34.27K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 8.62M shares of NRBO are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NRBO has 2.10M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NRBO is 0.87.